FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2321815754> ?p ?o ?g. }

• W2321815754 endingPage "205" @default.
• W2321815754 startingPage "196" @default.
• W2321815754 abstract "BACKGROUND: Research on readmissions has focused mainly on the economic and resource burden it places on hospitals. OBJECTIVE: To evaluate the effect of 30-day readmission on overall survival among newly diagnosed glioblastoma multiforme (GBM) patients. METHODS: A nationwide cohort of GBM patients diagnosed between 1991 and 2007 was studied using the Surveillance, Epidemiology and End Results Medicare database. Multivariate models were used to determine factors associated with readmission and overall survival. Odds ratio, hazard ratio, 95% confidence interval, and P values were reported. Complete case and multiple imputation analyses were performed. RESULTS: Among the 2774 newly diagnosed GBM patients undergoing surgery at 442 hospitals nationwide, 437 (15.8%) were readmitted within 30 days of the index hospitalization. Although 63% of readmitted patients returned to the index hospital where surgery was performed, a significant portion (37%) were readmitted to nonindex hospitals. The median overall survival for readmitted patients (6.0 months) was significantly shorter than for nonreadmitted (7.6 months; P < .001). In a confounder-adjusted imputed model, 30-day readmission increased the hazard of mortality by 30% (hazard ratio, 1.3; P < .001). Neurological symptoms (30.2%), thromboembolic complications (19.7%), and infections (17.6%) were the leading reasons for readmission. CONCLUSION: Prior studies that have reported only the readmissions back to index hospitals are likely underestimating the true 30-day readmission rate. GBM patients who were readmitted within 30 days had significantly shorter survival than nonreadmitted patients. Future studies that attempt to decrease readmissions and evaluate the impact of reducing readmissions on patient outcomes are needed. ABBREVIATIONS: CI, confidence interval GBM, glioblastoma multiforme ICD-9-CM, International Classification of Diseases, Ninth Revision, Clinical Modification SEER, Surveillance, Epidemiology and End Results" @default.
• W2321815754 created "2016-06-24" @default.
• W2321815754 creator A5000738174 @default.
• W2321815754 creator A5009418577 @default.
• W2321815754 creator A5016185028 @default.
• W2321815754 creator A5019253871 @default.
• W2321815754 creator A5031713170 @default.
• W2321815754 creator A5048403260 @default.
• W2321815754 creator A5085623146 @default.
• W2321815754 date "2014-02-01" @default.
• W2321815754 modified "2023-10-13" @default.
• W2321815754 title "Does 30-Day Readmission Affect Long-term Outcome Among Glioblastoma Patients?" @default.
• W2321815754 cites W1625002779 @default.
• W2321815754 cites W1972510157 @default.
• W2321815754 cites W1975425984 @default.
• W2321815754 cites W1977427217 @default.
• W2321815754 cites W1979454098 @default.
• W2321815754 cites W1981104285 @default.
• W2321815754 cites W1981995126 @default.
• W2321815754 cites W1992182047 @default.
• W2321815754 cites W1992482808 @default.
• W2321815754 cites W2004154456 @default.
• W2321815754 cites W2013210027 @default.
• W2321815754 cites W2015805049 @default.
• W2321815754 cites W2031383171 @default.
• W2321815754 cites W2033163059 @default.
• W2321815754 cites W2036742971 @default.
• W2321815754 cites W2046066969 @default.
• W2321815754 cites W2047179552 @default.
• W2321815754 cites W2080144905 @default.
• W2321815754 cites W2083225173 @default.
• W2321815754 cites W2086764191 @default.
• W2321815754 cites W2092385899 @default.
• W2321815754 cites W2096287682 @default.
• W2321815754 cites W2101787164 @default.
• W2321815754 cites W2102344329 @default.
• W2321815754 cites W2103634316 @default.
• W2321815754 cites W2115043622 @default.
• W2321815754 cites W2121186069 @default.
• W2321815754 cites W2122888903 @default.
• W2321815754 cites W2125449110 @default.
• W2321815754 cites W2126110877 @default.
• W2321815754 cites W2147016542 @default.
• W2321815754 cites W2157900680 @default.
• W2321815754 cites W2161216730 @default.
• W2321815754 cites W2170131723 @default.
• W2321815754 cites W2171858441 @default.
• W2321815754 doi "https://doi.org/10.1227/neu.0000000000000243" @default.
• W2321815754 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24176955" @default.
• W2321815754 hasPublicationYear "2014" @default.
• W2321815754 type Work @default.
• W2321815754 sameAs 2321815754 @default.
• W2321815754 citedByCount "45" @default.
• W2321815754 countsByYear W23218157542014 @default.
• W2321815754 countsByYear W23218157542015 @default.
• W2321815754 countsByYear W23218157542016 @default.
• W2321815754 countsByYear W23218157542017 @default.
• W2321815754 countsByYear W23218157542018 @default.
• W2321815754 countsByYear W23218157542019 @default.
• W2321815754 countsByYear W23218157542020 @default.
• W2321815754 countsByYear W23218157542021 @default.
• W2321815754 countsByYear W23218157542022 @default.
• W2321815754 countsByYear W23218157542023 @default.
• W2321815754 crossrefType "journal-article" @default.
• W2321815754 hasAuthorship W2321815754A5000738174 @default.
• W2321815754 hasAuthorship W2321815754A5009418577 @default.
• W2321815754 hasAuthorship W2321815754A5016185028 @default.
• W2321815754 hasAuthorship W2321815754A5019253871 @default.
• W2321815754 hasAuthorship W2321815754A5031713170 @default.
• W2321815754 hasAuthorship W2321815754A5048403260 @default.
• W2321815754 hasAuthorship W2321815754A5085623146 @default.
• W2321815754 hasConcept C107130276 @default.
• W2321815754 hasConcept C126322002 @default.
• W2321815754 hasConcept C156957248 @default.
• W2321815754 hasConcept C187212893 @default.
• W2321815754 hasConcept C194828623 @default.
• W2321815754 hasConcept C207103383 @default.
• W2321815754 hasConcept C38180746 @default.
• W2321815754 hasConcept C44249647 @default.
• W2321815754 hasConcept C50382708 @default.
• W2321815754 hasConcept C71924100 @default.
• W2321815754 hasConcept C77350462 @default.
• W2321815754 hasConceptScore W2321815754C107130276 @default.
• W2321815754 hasConceptScore W2321815754C126322002 @default.
• W2321815754 hasConceptScore W2321815754C156957248 @default.
• W2321815754 hasConceptScore W2321815754C187212893 @default.
• W2321815754 hasConceptScore W2321815754C194828623 @default.
• W2321815754 hasConceptScore W2321815754C207103383 @default.
• W2321815754 hasConceptScore W2321815754C38180746 @default.
• W2321815754 hasConceptScore W2321815754C44249647 @default.
• W2321815754 hasConceptScore W2321815754C50382708 @default.
• W2321815754 hasConceptScore W2321815754C71924100 @default.
• W2321815754 hasConceptScore W2321815754C77350462 @default.
• W2321815754 hasIssue "2" @default.
• W2321815754 hasLocation W23218157541 @default.
• W2321815754 hasLocation W23218157542 @default.
• W2321815754 hasOpenAccess W2321815754 @default.
• W2321815754 hasPrimaryLocation W23218157541 @default.

• next